Skip to main content

Table 1 Patient characteristics

From: COVID-19 vaccines in patients with decompensated cirrhosis: a retrospective cohort on safety data and risk factors associated with unvaccinated status

Variables

All (n = 229)

Without LT (n = 192)

LT recipients (n = 37)

P-value

Male, (%)

172 (75.1)

142 (74.0)

30 (81.1)

0.48

Age (years), mean (SD)

56.00 (12.15)

56.51 (12.54)

53.35 (9.61)

0.15

Systemic hypertension, (%)

40 (17.5)

32 (16.7)

8 (21.6)

0.62

Type II Diabetes, (%)

34 (14.8)

27 (14.1)

7 (18.9)

0.61

Etiology of cirrhosis, (%)

   

0.49

Viral

149 (65.1)

121 (63.0)

28 (75.7)

 

Alcohol

17 (7.4)

16 (8.3)

1 (2.7)

 

AIH

13 (5.7)

10 (5.2)

3 (8.1)

 

Cholestasis

10 (4.4)

9 (4.7)

1 (2.7)

 

Others

22 (9.6)

19 (9.9)

3 (8.1)

 

Multi

18 (7.9)

17 (8.9)

1 (2.7)

 

Experience of acute deterioration, (%)

    

Ascites (Grade II-III)

189 (82.5)

157 (81.8)

32 (86.5)

0.65

GEVB

18 (7.9)

13 (6.8)

5 (13.5)

0.29

HE

18 (7.9)

15 (7.8)

3 (8.1)

1.00

Bacterial/fungal infection

46 (20.1)

35 (18.2)

11 (29.7)

0.17

AKI

19 (8.3)

11 (5.7)

8 (21.6)

 < 0.01

ACLF

28 (12.2)

15 (7.8)

13 (35.1)

 < 0.001

Current living area (%)

    

Rural

95 (41.7)

83 (43.2)

12 (33.3)

0.36

Location

   

0.99

Shanghai

95 (41.5)

79 (41.1)

16 (43.2)

 

Zhejiang

49 (21.4)

42 (21.9)

7 (18.9)

 

Jiangsu

26 (11.4)

21 (10.9)

5 (13.5)

 

Jiangxi

27 (11.8)

23 (12.0)

4 (10.8)

 

Anhui

16 (7.0)

14 (7.3)

2 (5.4)

 

Others

16 (7.0)

13 (6.8)

3 (8.1)

 
  1. Values are number (%) for categorical variables and mean (SD) for Age
  2. AIH auto-immune hepatitis, GEVB gastro-esophageal varices bleeding, HE hepatic encephalopathy, AKI acute kidney injury, ACLF acute-on-chronic liver failure, LT liver transplant, SD Standard deviation